Novartis AG (NVS) Earnings
|
Expand Research on NVS
| Next EPS Date | 7/21/26 | EPS Growth Rate | -9.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.3% | Revenue Growth Rate | +0.7% |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/21/26  |
Q226 | N/A | $2.18 | N/A | N/A | $14.15B | N/A | N/A | N/A | ||
| 4/28/26 |
Q126 | N/A | $2.10 | N/A | N/A | $13.51B | N/A | N/A | N/A | ||
| 2/4/26 |
Q425 | N/A | $1.97 | N/A | N/A | $13.88B | N/A | N/A | N/A | ||
| 10/28/25 |
Q325 | $2.25 | $2.27 | -$0.02 | $13.91B | $13.89B | N/A |  | | Details | |
| 7/17/25 |
Q225 | $2.42 | $2.35 | +$0.07 | $14.05B | $14.02B | N/A | | | Details | |
| 4/29/25 |
Q125 | $2.28 | N/A | N/A | $13.23B | $13.03B | N/A | | | Details | |
| 1/31/25 |
Q424 | $1.98 | $1.82 | +$0.16 | $13.15B | $12.99B | N/A | | | Details | |
| 10/29/24 | Q324 | $2.06 | $1.94 | +$0.12 | $12.82B | $12.79B | N/A | | | Details |
